GLP-1 psychological side effects: a psychiatrist’s view
As a physician-psychiatrist, I have watched the rise of GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) with genuine admiration. They are transforming metabolic health, reducing cardiovascular risk, and offering hope to patients who have struggled for decades. For many, these medications are lifesaving.
But alongside the excitement, I’m witnessing something rarely discussed: a change in personality and affect, especially at higher doses.
This pattern reminds me of the early days of SSRIs. When …
GLP-1 psychological side effects: a psychiatrist’s view












![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)



![Why hospital systems fail to notice the human behind the bill [PODCAST]](https://kevinmd.com/wp-content/uploads/ea65fd1d-d282-4c46-a750-620a3c3bb42f-190x100.jpeg)


